| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.2M | — | +63.0% |
| R&D Expense | $36K | — | +18.5% |
| SG&A Expense | $2.9M | — | +4.0% |
| Operating Income | -$277K | — | +82.1% |
| Interest Expense | $973K | — | +9.4% |
| Pre-tax Income | -$1.5M | — | -134.4% |
| Net Income | -$1.5M | — | -135.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $66K | -68.2% | +289.8% |
| Accounts Receivable | $3.9M | +58.4% | +47.3% |
| Inventory | $189K | +2.7% | — |
| Current Assets | $4.5M | +44.2% | +40.5% |
| Total Assets | $45.8M | +2.7% | +9.3% |
| Current Liabilities | $31.6M | +10.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$578K | — | +56.8% |
| Capital Expenditures | $4K | — | — |
| Investing Cash Flow | -$4K | — | — |
| Financing Cash Flow | $440K | — | -65.8% |
| Free Cash Flow | -$582K | — | — |
| +10.1% |
| Total Liabilities | $36.2M | +7.9% | +12.2% |
| Stockholders' Equity | $9.7M | -12.9% | -0.0% |